{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T13:09:08Z","timestamp":1792069748212,"version":"4.4.0"},"reference-count":96,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T00:00:00Z","timestamp":1761782400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T00:00:00Z","timestamp":1761782400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"NIH\/NCI","award":["P30CA016087"],"award-info":[{"award-number":["P30CA016087"]}]},{"name":"NIH\/NCI","award":["P30CA016087"],"award-info":[{"award-number":["P30CA016087"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-21866-x","type":"journal-article","created":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T13:17:58Z","timestamp":1761830278000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Regulating white blood cell activity through the novel universal receptive system"],"prefix":"10.1038","volume":"15","author":[{"given":"Victor","family":"Tetz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Kardava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Vecherkovskaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza","family":"Khodadadi-Jamayran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aristotelis","family":"Tsirigos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Tetz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,30]]},"reference":[{"key":"21866_CR1","doi-asserted-by":"publisher","first-page":"166634","DOI":"10.1016\/j.jmb.2020.08.019","volume":"433","author":"L Wang","year":"2021","unstructured":"Wang, L. et al. HSP70, a novel regulatory molecule in B cell-mediated suppression of autoimmune diseases. J. Mol. Biol. 433, 166634 (2021).","journal-title":"J. Mol. Biol."},{"key":"21866_CR2","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1038\/s41551-023-01102-5","volume":"8","author":"AV Stepanov","year":"2023","unstructured":"Stepanov, A. V. et al. Control of the antitumour activity and specificity of CAR T cells via organic adapters covalently tethering the CAR to tumour cells. Nat. Biomed. Eng. 8, 529\u2013543 (2023).","journal-title":"Nat. Biomed. Eng."},{"key":"21866_CR3","doi-asserted-by":"publisher","first-page":"2575","DOI":"10.4049\/jimmunol.1901213","volume":"204","author":"Z Zhang","year":"2020","unstructured":"Zhang, Z. et al. Metformin enhances the antitumor activity of CD8\u2009+\u2009T lymphocytes via the AMPK\u2013miR-107\u2013Eomes\u2013PD-1 pathway. J. Immunol. 204, 2575\u20132588 (2020).","journal-title":"J. Immunol."},{"key":"21866_CR4","doi-asserted-by":"publisher","unstructured":"Poli, A. et al. PIP4Ks impact on PI3K, FOXP3, and UHRF1 signaling and modulate human regulatory T cell proliferation and immunosuppressive activity. Proc. Natl. Acad. Sci. 118 https:\/\/doi.org\/10.1073\/pnas.2010053118 (2021).","DOI":"10.1073\/pnas.2010053118"},{"key":"21866_CR5","doi-asserted-by":"publisher","first-page":"7687","DOI":"10.1038\/s41598-022-11364-9","volume":"12","author":"E Duthoo","year":"2022","unstructured":"Duthoo, E., Vral, A. & Baeyens, A. An updated view into the cell cycle kinetics of human T lymphocytes and the impact of irradiation. Sci. Rep. 12, 7687 (2022).","journal-title":"Sci. Rep."},{"key":"21866_CR6","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1038\/s41423-020-00530-6","volume":"18","author":"J Varad\u00e9","year":"2021","unstructured":"Varad\u00e9, J., Magad\u00e1n, S. & Gonz\u00e1lez-Fern\u00e1ndez, \u00c1. Human immunology and immunotherapy: main achievements and challenges. Cell. Mol. Immunol. 18, 805\u2013828 (2021).","journal-title":"Cell. Mol. Immunol."},{"key":"21866_CR7","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3390\/receptors1010003","volume":"1","author":"V Tetz","year":"2022","unstructured":"Tetz, V. & Tetz, G. Novel cell receptor system of eukaryotes formed by previously unknown nucleic acid-based receptors. Receptors 1, 13\u201353 (2022).","journal-title":"Receptors"},{"key":"21866_CR8","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1186\/s12934-022-01923-0","volume":"21","author":"V Tetz","year":"2022","unstructured":"Tetz, V. & Tetz, G. Novel prokaryotic system employing previously unknown nucleic acids-based receptors. Microb. Cell. Fact. 21, 202 (2022).","journal-title":"Microb. Cell. Fact."},{"key":"21866_CR9","doi-asserted-by":"publisher","first-page":"9789","DOI":"10.1038\/s41467-024-53960-5","volume":"15","author":"H Chen","year":"2024","unstructured":"Chen, H. et al. Oriented triplex DNA as a synthetic receptor for transmembrane signal transduction. Nat. Commun. 15, 9789 (2024).","journal-title":"Nat. Commun."},{"key":"21866_CR10","first-page":"2024-07","volume":"12","author":"V Tetz","year":"2024","unstructured":"Tetz, V. et al. Previously unknown regulatory role of extracellular RNA on bacterial directional migration. bioRxiv 12, 2024-07 (2024).","journal-title":"bioRxiv"},{"key":"21866_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12934-024-02637-1","volume":"24","author":"G Tetz","year":"2025","unstructured":"Tetz, G. et al. Universal receptive system as a novel regulator of transcriptomic activity of Staphylococcus aureus. Microb. Cell. Fact. 24, 1 (2025).","journal-title":"Microb. Cell. Fact."},{"key":"21866_CR12","doi-asserted-by":"publisher","DOI":"10.2217\/fmb-2023-0003","author":"G Tetz","year":"2023","unstructured":"Tetz, G. & Tetz, V. Introducing the extrabiome and its classification: a new view on extracellular nucleic acids. Future Microbiol. https:\/\/doi.org\/10.2217\/fmb-2023-0003 (2023).","journal-title":"Future Microbiol."},{"key":"21866_CR13","doi-asserted-by":"publisher","unstructured":"Tetz, V. et al. The universal receptive system: a novel regulator of antimicrobial and anticancer compound production by white blood cells. J. Leukoc. Biol. 117 https:\/\/doi.org\/10.1093\/jleuko\/qiaf085 (2025).","DOI":"10.1093\/jleuko\/qiaf085"},{"key":"21866_CR14","doi-asserted-by":"publisher","unstructured":"Tetz, V. & Tetz, G. Bacterial DNA induces the formation of heat-resistant disease-associated proteins in human plasma. Sci. Rep. 9 https:\/\/doi.org\/10.1038\/s41598-019-54618-9 (2019).","DOI":"10.1038\/s41598-019-54618-9"},{"key":"21866_CR15","doi-asserted-by":"publisher","unstructured":"Tetz, G. & Tetz, V. Bacterial extracellular DNA promotes \u03b2-Amyloid aggregation. Microorganisms 9 https:\/\/doi.org\/10.3390\/microorganisms9061301 (2021).","DOI":"10.3390\/microorganisms9061301"},{"key":"21866_CR16","doi-asserted-by":"publisher","unstructured":"Tetz, G. et al. Bacterial DNA promotes Tau aggregation. Sci. Rep. 10 https:\/\/doi.org\/10.1038\/s41598-020-59364-x (2020).","DOI":"10.1038\/s41598-020-59364-x"},{"key":"21866_CR17","doi-asserted-by":"publisher","unstructured":"Wang, R. et al. The interaction of innate immune and adaptive immune system. MedComm 5 https:\/\/doi.org\/10.1002\/mco2.714 (2024).","DOI":"10.1002\/mco2.714"},{"key":"21866_CR18","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.it.2024.09.011","volume":"45","author":"DP van Hoytema","year":"2024","unstructured":"van Hoytema, D. P., Nigrovic, P. A. & Zanoni, I. Regional specialization within the mammalian respiratory immune system. Trends Immunol. 45, 871\u2013891 (2024).","journal-title":"Trends Immunol."},{"key":"21866_CR19","doi-asserted-by":"publisher","first-page":"5047","DOI":"10.1158\/1078-0432.CCR-15-0685","volume":"21","author":"L Mart\u00ednez-Lostao","year":"2015","unstructured":"Mart\u00ednez-Lostao, L., Anel, A. & Pardo, J. How do cytotoxic lymphocytes kill cancer cells? Clin. Cancer Res. 21, 5047\u20135056 (2015).","journal-title":"Clin. Cancer Res."},{"key":"21866_CR20","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1182\/asheducation-2013.1.234","volume":"2013","author":"RW Childs","year":"2013","unstructured":"Childs, R. W. & Berg, M. Bringing natural killer cells to the clinic: ex vivo manipulation. Hematology 2013, 234\u2013246 (2013).","journal-title":"Hematology"},{"key":"21866_CR21","doi-asserted-by":"publisher","unstructured":"Sudarsanam, H., Buhmann, R. & Henschler, R. Influence of culture conditions on ex vivo expansion of t lymphocytes and their function for therapy: current insights and open questions. Front. Bioeng. Biotechnol. 10 https:\/\/doi.org\/10.3389\/fbioe.2022.886637 (2022).","DOI":"10.3389\/fbioe.2022.886637"},{"key":"21866_CR22","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1007\/s00262-010-0833-1","volume":"59","author":"G Schreibelt","year":"2010","unstructured":"Schreibelt, G. et al. Toll-like receptor expression and function in human dendritic cell subsets: implications for dendritic cell-based anti-cancer immunotherapy. Cancer Immunol. Immunother. 59, 1573\u20131582 (2010).","journal-title":"Cancer Immunol. Immunother"},{"key":"21866_CR23","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1182\/blood-2020-140753","volume":"136","author":"R Devillier","year":"2020","unstructured":"Devillier, R. et al. Phase 1 trial of prophylactic donor-derived IL-2 activated NK cell infusion after allogeneic hematopoietic stem cell transplantation from a matched sibling donor. Blood 136, 6\u20137 (2020).","journal-title":"Blood"},{"key":"21866_CR24","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s40364-017-0102-y","volume":"5","author":"C Zhang","year":"2017","unstructured":"Zhang, C. et al. Engineering CAR-T cells. Biomark. Res. 5, 22 (2017).","journal-title":"Biomark. Res."},{"key":"21866_CR25","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/s41568-020-00323-z","volume":"21","author":"RC Larson","year":"2021","unstructured":"Larson, R. C. & Maus, M. V. Recent advances and discoveries in the mechanisms and functions of CAR T cells. Nat. Rev. Cancer. 21, 145\u2013161 (2021).","journal-title":"Nat. Rev. Cancer"},{"key":"21866_CR26","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1038\/s41375-019-0455-3","volume":"33","author":"J Huang","year":"2019","unstructured":"Huang, J. et al. Unique CDR3 epitope targeting by CAR-T cells is a viable approach for treating T-cell malignancies. Leukemia 33, 2315\u20132319 (2019).","journal-title":"Leukemia"},{"key":"21866_CR27","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/s41571-020-0427-6","volume":"18","author":"L Mikkilineni","year":"2021","unstructured":"Mikkilineni, L. & Kochenderfer, J. N. CAR T cell therapies for patients with multiple myeloma. Nat. Rev. Clin. Oncol. 18, 71\u201384 (2021).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"21866_CR28","doi-asserted-by":"publisher","unstructured":"Davila, M. L. et al. Efficacy and toxicity management of 19-28z CAR T cell therapy in B cell acute lymphoblastic leukemia. Sci. Transl Med. 6 https:\/\/doi.org\/10.1126\/scitranslmed.3008226 (2014).","DOI":"10.1126\/scitranslmed.3008226"},{"key":"21866_CR29","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1126\/science.aar6711","volume":"359","author":"CH June","year":"2018","unstructured":"June, C. H. et al. CAR T cell immunotherapy for human cancer. Sci. (80-). 359, 1361\u20131365 (2018).","journal-title":"Sci. (80-)"},{"key":"21866_CR30","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1007\/s00262-020-02760-z","volume":"70","author":"M Presti","year":"2021","unstructured":"Presti, M. et al. The effects of targeted immune-regulatory strategies on tumor-specific T-cell responses in vitro. Cancer Immunol. Immunother. 70, 1771\u20131776 (2021).","journal-title":"Cancer Immunol. Immunother"},{"key":"21866_CR31","doi-asserted-by":"publisher","unstructured":"Yu, L. et al. T cell immunotherapy for cervical cancer: challenges and opportunities. Front. Immunol. 14 https:\/\/doi.org\/10.3389\/fimmu.2023.1105265 (2023).","DOI":"10.3389\/fimmu.2023.1105265"},{"key":"21866_CR32","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s41571-023-00832-4","volume":"21","author":"SM Albelda","year":"2024","unstructured":"Albelda, S. M. CAR T cell therapy for patients with solid tumours: key lessons to learn and unlearn. Nat. Rev. Clin. Oncol. 21, 47\u201366 (2024).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"21866_CR33","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/s41419-018-0278-6","volume":"9","author":"MM D\u2019Aloia","year":"2018","unstructured":"D\u2019Aloia, M. M. et al. CAR-T cells: the long and winding road to solid tumors. Cell. Death Dis. 9, 282 (2018).","journal-title":"Cell. Death Dis."},{"key":"21866_CR34","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1002\/(SICI)1097-0029(19980701)42:1<43::AID-JEMT6>3.0.CO;2-S","volume":"42","author":"BM Humbel","year":"1998","unstructured":"Humbel, B. M. et al. Pre-embedding Immunolabeling for electron microscopy: an evaluation of permeabilization methods and markers. Microsc Res. Tech. 42, 43\u201358 (1998).","journal-title":"Microsc Res. Tech."},{"key":"21866_CR35","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.ijantimicag.2017.02.011","volume":"50","author":"G Tetz","year":"2017","unstructured":"Tetz, G. et al. In vitro activity of a novel compound, Mul-1867, against clinically significant fungi Candida spp. And Aspergillus spp. Int. J. Antimicrob. Agents. 50, 47\u201354 (2017).","journal-title":"Int. J. Antimicrob. Agents"},{"key":"21866_CR36","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/nprot.2007.521","volume":"3","author":"I Wiegand","year":"2008","unstructured":"Wiegand, I., Hilpert, K. & Hancock, R. E. W. Agar and broth Dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances. Nat. Protoc. 3, 163\u2013175 (2008).","journal-title":"Nat. Protoc."},{"key":"21866_CR37","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1111\/j.1365-2591.1988.tb00956.x","volume":"21","author":"SCHMALZ G","year":"1988","unstructured":"SCHMALZ G. Agar overlay method. Int. Endod J. 21, 59\u201366 (1988).","journal-title":"Int. Endod J."},{"key":"21866_CR38","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s10020-022-00435-2","volume":"28","author":"R Mirzaei","year":"2022","unstructured":"Mirzaei, R. et al. Immunometabolism in biofilm infection: lessons from cancer. Mol. Med. 28, 10 (2022).","journal-title":"Mol. Med."},{"key":"21866_CR39","doi-asserted-by":"publisher","first-page":"2690","DOI":"10.1016\/j.cell.2023.05.008","volume":"186","author":"L Vidakovic","year":"2023","unstructured":"Vidakovic, L. et al. Biofilm formation on human immune cells is a multicellular predation strategy of vibrio cholerae. Cell 186, 2690\u20132704e20 (2023).","journal-title":"Cell"},{"key":"21866_CR40","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1182\/blood.V128.22.302.302","volume":"128","author":"X-J Yan","year":"2016","unstructured":"Yan, X-J. et al. B cells of the proliferative fraction of CLL clones exhibit activated B-Cell and myeloid-cell signatures suggesting enhanced antigen-presentation, integrin responsiveness, and IL-4 receptiveness: additional targets for CLL therapy. Blood 128, 302\u2013302 (2016).","journal-title":"Blood"},{"key":"21866_CR41","doi-asserted-by":"publisher","first-page":"16134","DOI":"10.1038\/s41598-021-95718-9","volume":"11","author":"I Mito","year":"2021","unstructured":"Mito, I. et al. Comprehensive analysis of immune cell enrichment in the tumor microenvironment of head and neck squamous cell carcinoma. Sci. Rep. 11, 16134 (2021).","journal-title":"Sci. Rep."},{"key":"21866_CR42","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/s41392-024-01868-3","volume":"9","author":"M Yi","year":"2024","unstructured":"Yi, M. et al. Targeting cytokine and chemokine signaling pathways for cancer therapy. Signal. Transduct. Target. Ther. 9, 176 (2024).","journal-title":"Signal. Transduct. Target. Ther."},{"key":"21866_CR43","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1136\/gut.52.1.144","volume":"52","author":"DW Hommes","year":"2003","unstructured":"Hommes, D. W. Mitogen activated protein (MAP) kinase signal transduction pathways and novel anti-inflammatory targets. Gut 52, 144\u2013151 (2003).","journal-title":"Gut"},{"key":"21866_CR44","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/nri3495","volume":"13","author":"JSC Arthur","year":"2013","unstructured":"Arthur, J. S. C. & Ley, S. C. Mitogen-activated protein kinases in innate immunity. Nat. Rev. Immunol. 13, 679\u2013692 (2013).","journal-title":"Nat. Rev. Immunol."},{"key":"21866_CR45","first-page":"3","volume":"15","author":"JA Rankin","year":"2004","unstructured":"Rankin, J. A. Biological mediators of acute inflammation. AACN Clin. Issues Adv. Pract. Acute Crit. Care. 15, 3\u201317 (2004).","journal-title":"AACN Clin. Issues Adv. Pract. Acute Crit. Care"},{"key":"21866_CR46","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1007\/s00018-016-2449-x","volume":"74","author":"M Schnoor","year":"2017","unstructured":"Schnoor, M. et al. Actin dynamics in the regulation of endothelial barrier functions and neutrophil recruitment during endotoxemia and sepsis. Cell. Mol. Life Sci. 74, 1985\u20131997 (2017).","journal-title":"Cell. Mol. Life Sci."},{"key":"21866_CR47","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1016\/j.ajpath.2013.12.033","volume":"184","author":"WA Muller","year":"2014","unstructured":"Muller, W. A. How endothelial cells regulate transmigration of leukocytes in the inflammatory response. Am. J. Pathol. 184, 886\u2013896 (2014).","journal-title":"Am. J. Pathol."},{"key":"21866_CR48","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.semcdb.2014.03.002","volume":"31","author":"PA Gleeson","year":"2014","unstructured":"Gleeson, P. A. The role of endosomes in innate and adaptive immunity. Semin Cell. Dev. Biol. 31, 64\u201372 (2014).","journal-title":"Semin Cell. Dev. Biol."},{"key":"21866_CR49","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.imbio.2015.12.003","volume":"221","author":"Q Zhu","year":"2016","unstructured":"Zhu, Q. et al. Human B cells have an active phagocytic capability and undergo immune activation upon phagocytosis of Mycobacterium tuberculosis. Immunobiology 221, 558\u2013567 (2016).","journal-title":"Immunobiology"},{"key":"21866_CR50","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1016\/j.cell.2018.01.004","volume":"172","author":"JP B\u00f6ttcher","year":"2018","unstructured":"B\u00f6ttcher, J. P. et al. NK cells stimulate recruitment of cdc1 into the tumor microenvironment promoting cancer immune control. Cell 172, 1022\u20131037e14 (2018).","journal-title":"Cell"},{"key":"21866_CR51","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1016\/j.bbrc.2017.09.113","volume":"493","author":"YJ Guo","year":"2017","unstructured":"Guo, Y. J. et al. The role and clinical significance of the CXCL17-CXCR8 (GPR35) axis in breast cancer. Biochem. Biophys. Res. Commun. 493, 1159\u20131167 (2017).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"21866_CR52","doi-asserted-by":"publisher","first-page":"5455","DOI":"10.1158\/0008-5472.CAN-11-1687","volume":"71","author":"A Gonz\u00e1lez-Mart\u00edn","year":"2011","unstructured":"Gonz\u00e1lez-Mart\u00edn, A. et al. Maximal T cell\u2013mediated antitumor responses rely upon ccr5 expression in both CD4\u2009+\u2009and CD8\u2009+\u2009T cells. Cancer Res. 71, 5455\u20135466 (2011).","journal-title":"Cancer Res."},{"key":"21866_CR53","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.immuni.2015.07.009","volume":"43","author":"A Bunin","year":"2015","unstructured":"Bunin, A. et al. Protein tyrosine phosphatase PTPRS is an inhibitory receptor on human and murine plasmacytoid dendritic cells. Immunity 43, 277\u2013288 (2015).","journal-title":"Immunity"},{"key":"21866_CR54","doi-asserted-by":"publisher","first-page":"8369","DOI":"10.4049\/jimmunol.180.12.8369","volume":"180","author":"A Chorny","year":"2008","unstructured":"Chorny, A. et al. Ghrelin protects against experimental sepsis by inhibiting high-mobility group box 1 release and by killing bacteria. J. Immunol. 180, 8369\u20138377 (2008).","journal-title":"J. Immunol."},{"key":"21866_CR55","doi-asserted-by":"publisher","first-page":"2848","DOI":"10.3390\/ijms19102848","volume":"19","author":"A Ja\u015bkiewicz","year":"2018","unstructured":"Ja\u015bkiewicz, A., Paj\u0105k, B. & Orzechowski, A. The many faces of rap1 GTPase. Int. J. Mol. Sci. 19, 2848 (2018).","journal-title":"Int. J. Mol. Sci."},{"key":"21866_CR56","doi-asserted-by":"publisher","unstructured":"Brandt, A. C., Koehn, O. J. & Williams, C. L. SmgGDS: an emerging master regulator of prenylation and trafficking by small GTPases in the Ras and Rho families. Front. Mol. Biosci. 8 https:\/\/doi.org\/10.3389\/fmolb.2021.685135 (2021).","DOI":"10.3389\/fmolb.2021.685135"},{"key":"21866_CR57","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s00005-012-0199-5","volume":"61","author":"M-L Arcangeli","year":"2013","unstructured":"Arcangeli, M-L., Frontera, V. & Aurrand-Lions, M. Function of junctional adhesion molecules (JAMs) in leukocyte migration and homeostasis. Arch. Immunol. Ther. Exp. (Warsz). 61, 15\u201323 (2013).","journal-title":"Arch. Immunol. Ther. Exp. (Warsz)"},{"key":"21866_CR58","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1084\/jem.20060565","volume":"203","author":"F Wegmann","year":"2006","unstructured":"Wegmann, F. et al. ESAM supports neutrophil extravasation, activation of Rho, and VEGF-induced vascular permeability. J. Exp. Med. 203, 1671\u20131677 (2006).","journal-title":"J. Exp. Med."},{"key":"21866_CR59","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.tcb.2010.10.003","volume":"21","author":"N Naslavsky","year":"2011","unstructured":"Naslavsky, N. & Caplan, S. EHD proteins: key conductors of endocytic transport. Trends Cell. Biol. 21, 122\u2013131 (2011).","journal-title":"Trends Cell. Biol."},{"key":"21866_CR60","doi-asserted-by":"publisher","unstructured":"Ahuja, S. & Lazar, I. M. Systems-level proteomics evaluation of microglia response to tumor-supportive anti-inflammatory cytokines. Front. Immunol. 12 https:\/\/doi.org\/10.3389\/fimmu.2021.646043 (2021).","DOI":"10.3389\/fimmu.2021.646043"},{"key":"21866_CR61","doi-asserted-by":"publisher","first-page":"e38608","DOI":"10.1016\/j.heliyon.2024.e38608","volume":"10","author":"J-X Zhang","year":"2024","unstructured":"Zhang, J-X. et al. ANXA3 as a novel biomarker for sepsis diagnosis: evidence from integrative WGCNA analysis. Heliyon 10, e38608 (2024).","journal-title":"Heliyon"},{"key":"21866_CR62","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/bs.ctm.2018.07.004","volume":"81","author":"Y Okada","year":"2018","unstructured":"Okada, Y., Okada, T., Islam, M. R. & Sabirov, R. Z. Molecular identities and ATP release activities of two types of volume-regulatory anion channels, VSOR and Maxi-Cl. Curr. Top. Membr. 81, 125\u2013176 (2018).","journal-title":"Curr. Top. Membr."},{"key":"21866_CR63","doi-asserted-by":"publisher","first-page":"C558","DOI":"10.1152\/ajpcell.00276.2022","volume":"324","author":"F Dion\u00edsio","year":"2023","unstructured":"Dion\u00edsio, F., Tomas, L. & Schulz, C. Glycolytic side pathways regulating macrophage inflammatory phenotypes and functions. Am. J. Physiol. Physiol. 324, C558\u2013C564 (2023).","journal-title":"Am. J. Physiol. Physiol."},{"key":"21866_CR64","doi-asserted-by":"publisher","first-page":"383","DOI":"10.7150\/jca.88359","volume":"15","author":"Z Zhang","year":"2024","unstructured":"Zhang, Z. et al. Comprehensive analysis based on glycolytic and glutaminolytic pathways signature for predicting prognosis and immunotherapy in ovarian cancer. J. Cancer. 15, 383\u2013400 (2024).","journal-title":"J. Cancer"},{"key":"21866_CR65","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.cmet.2017.08.012","volume":"26","author":"PM Thwe","year":"2017","unstructured":"Thwe, P. M. et al. Cell-intrinsic glycogen metabolism supports early glycolytic reprogramming required for dendritic cell immune responses. Cell. Metab. 26, 558\u2013567e5 (2017).","journal-title":"Cell. Metab."},{"key":"21866_CR66","doi-asserted-by":"publisher","unstructured":"Li, C. et al. Pyruvate dehydrogenase kinase regulates macrophage polarization in metabolic and inflammatory diseases. Front. Immunol. 14 https:\/\/doi.org\/10.3389\/fimmu.2023.1296687 (2023).","DOI":"10.3389\/fimmu.2023.1296687"},{"key":"21866_CR67","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/nrg3606","volume":"15","author":"A Fatica","year":"2014","unstructured":"Fatica, A. & Bozzoni, I. Long non-coding rnas: new players in cell differentiation and development. Nat. Rev. Genet. 15, 7\u201321 (2014).","journal-title":"Nat. Rev. Genet."},{"key":"21866_CR68","doi-asserted-by":"publisher","first-page":"109167","DOI":"10.1016\/j.clim.2022.109167","volume":"245","author":"X Liu","year":"2022","unstructured":"Liu, X. et al. Long non-coding RNA: multiple effects on the differentiation, maturity and cell function of dendritic cells. Clin. Immunol. 245, 109167 (2022).","journal-title":"Clin. Immunol."},{"key":"21866_CR69","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1111\/imr.12055","volume":"253","author":"M Pagani","year":"2013","unstructured":"Pagani, M. et al. Role of microRNA s and long-non\u2010codingRNA s in CD\u20094 + T\u2010cell differentiation. Immunol. Rev. 253, 82\u201396 (2013).","journal-title":"Immunol. Rev."},{"key":"21866_CR70","doi-asserted-by":"publisher","unstructured":"Lee, M. K. S. et al. Glycolysis is required for LPS-induced activation and adhesion of human CD14\u2009+\u2009CD16\u2009\u2013\u2009monocytes. Front. Immunol. 10 https:\/\/doi.org\/10.3389\/fimmu.2019.02054 (2019).","DOI":"10.3389\/fimmu.2019.02054"},{"key":"21866_CR71","doi-asserted-by":"publisher","first-page":"3350","DOI":"10.1111\/febs.15327","volume":"287","author":"G Soto-Heredero","year":"2020","unstructured":"Soto-Heredero, G. et al. Glycolysis \u2013 a key player in the inflammatory response. FEBS J. 287, 3350\u20133369 (2020).","journal-title":"FEBS J."},{"key":"21866_CR72","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s004030050144","volume":"289","author":"H Jonuleit","year":"1996","unstructured":"Jonuleit, H., Knop, J. & Enk, A. H. Cytokines and their effects on maturation, differentiation and migration of dendritic cells. Arch. Dermatol. Res. 289, 1\u20138 (1996).","journal-title":"Arch. Dermatol. Res."},{"key":"21866_CR73","doi-asserted-by":"publisher","first-page":"106939","DOI":"10.1016\/j.intimp.2020.106939","volume":"88","author":"L Li","year":"2020","unstructured":"Li, L. et al. Effects of immune cells and cytokines on inflammation and immunosuppression in the tumor microenvironment. Int. Immunopharmacol. 88, 106939 (2020).","journal-title":"Int. Immunopharmacol."},{"key":"21866_CR74","doi-asserted-by":"publisher","unstructured":"Arango Duque, G. & Descoteaux, A. Macrophage cytokines: involvement in immunity and infectious diseases. Front. Immunol. 5 https:\/\/doi.org\/10.3389\/fimmu.2014.00491 (2014).","DOI":"10.3389\/fimmu.2014.00491"},{"key":"21866_CR75","doi-asserted-by":"publisher","first-page":"4196","DOI":"10.4049\/jimmunol.1202688","volume":"190","author":"P Jayaraman","year":"2013","unstructured":"Jayaraman, P. et al. IL-1\u03b2 promotes antimicrobial immunity in macrophages by regulating TNFR signaling and caspase-3 activation. J. Immunol. 190, 4196\u20134204 (2013).","journal-title":"J. Immunol."},{"key":"21866_CR76","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1007\/s12032-024-02326-4","volume":"41","author":"S Hosseinzadeh","year":"2024","unstructured":"Hosseinzadeh, S. et al. Combination of IFN-gamma with STING agonist and PD-1 immune checkpoint blockade: a potential immunotherapy for gastric cancer. Med. Oncol. 41, 110 (2024).","journal-title":"Med. Oncol."},{"key":"21866_CR77","doi-asserted-by":"publisher","first-page":"101280","DOI":"10.1016\/j.smim.2019.05.002","volume":"43","author":"JD Burke","year":"2019","unstructured":"Burke, J. D. & Young, H. A. IFN-\u03b3: A cytokine at the right time, is in the right place. Semin Immunol. 43, 101280 (2019).","journal-title":"Semin Immunol."},{"key":"21866_CR78","doi-asserted-by":"publisher","first-page":"5771","DOI":"10.4049\/jimmunol.180.9.5771","volume":"180","author":"KN Couper","year":"2008","unstructured":"Couper, K. N., Blount, D. G. & Riley, E. M. IL-10: the master regulator of immunity to infection. J. Immunol. 180, 5771\u20135777 (2008).","journal-title":"J. Immunol."},{"key":"21866_CR79","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.canlet.2014.12.003","volume":"357","author":"L Yang","year":"2015","unstructured":"Yang, L. et al. Mutations of p53 and KRAS activate NF-\u03baB to promote chemoresistance and tumorigenesis via dysregulation of cell cycle and suppression of apoptosis in lung cancer cells. Cancer Lett. 357, 520\u2013526 (2015).","journal-title":"Cancer Lett."},{"key":"21866_CR80","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.28.1.119","author":"C-M Park","year":"2006","unstructured":"Park, C-M. et al. Induction of p53-mediated apoptosis and recovery of chemosensitivity through p53 transduction in human glioblastoma cells by cisplatin. Int. J. Oncol. https:\/\/doi.org\/10.3892\/ijo.28.1.119 (2006).","journal-title":"Int. J. Oncol."},{"key":"21866_CR81","doi-asserted-by":"publisher","unstructured":"Tetz, V. et al. The universal receptive system acts as a novel regulator in the production of antimicrobial and anticancer bioactive compounds by white blood cells. (2024). https:\/\/doi.org\/10.1101\/2024.12.17.628964","DOI":"10.1101\/2024.12.17.628964"},{"key":"21866_CR82","doi-asserted-by":"publisher","first-page":"5145","DOI":"10.1074\/jbc.M111.257634","volume":"287","author":"J-G Kim","year":"2012","unstructured":"Kim, J-G. et al. Ras-related GTPases Rap1 and RhoA collectively induce the phagocytosis of serum-opsonized zymosan particles in macrophages. J. Biol. Chem. 287, 5145\u20135155 (2012).","journal-title":"J. Biol. Chem."},{"key":"21866_CR83","doi-asserted-by":"publisher","unstructured":"Pearce, E. L. et al. Fueling immunity: insights into metabolism and lymphocyte function. Sci. (80-). 342 https:\/\/doi.org\/10.1126\/science.1242454 (2013).","DOI":"10.1126\/science.1242454"},{"key":"21866_CR84","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1038\/nprot.2010.43","volume":"5","author":"L Young","year":"2010","unstructured":"Young, L. et al. Detection of Mycoplasma in cell cultures. Nat. Protoc. 5, 929\u2013934 (2010).","journal-title":"Nat. Protoc."},{"key":"21866_CR85","doi-asserted-by":"publisher","first-page":"116182","DOI":"10.1016\/j.jpba.2024.116182","volume":"246","author":"S Zia","year":"2024","unstructured":"Zia, S. et al. Emerging technologies for quality control of cell-based, advanced therapy medicinal products. J. Pharm. Biomed. Anal. 246, 116182 (2024).","journal-title":"J. Pharm. Biomed. Anal."},{"key":"21866_CR86","doi-asserted-by":"publisher","first-page":"10","DOI":"10.14806\/ej.17.1.200","volume":"17","author":"M Martin","year":"2011","unstructured":"Martin, M. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet J. 17, 10 (2011).","journal-title":"EMBnet J."},{"key":"21866_CR87","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15\u201321 (2013).","journal-title":"Bioinformatics"},{"key":"21866_CR88","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1093\/bioinformatics\/btu638","volume":"31","author":"S Anders","year":"2015","unstructured":"Anders, S., Pyl, P. T. & Huber, W. HTSeq\u2014a python framework to work with high-throughput sequencing data. Bioinformatics 31, 166\u2013169 (2015).","journal-title":"Bioinformatics"},{"key":"21866_CR89","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated Estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."},{"key":"21866_CR90","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1093\/bioinformatics\/btq033","volume":"26","author":"AR Quinlan","year":"2010","unstructured":"Quinlan, A. R. & Hall, I. M. BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics 26, 841\u2013842 (2010).","journal-title":"Bioinformatics"},{"key":"21866_CR91","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. 102, 15545\u201315550 (2005).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"21866_CR92","unstructured":"Clinical and Laboratory Standards Institute (CLSI). Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts; Approved Standard\u2014Third Edition. CLSI document M27-A3 (ISBN 1-56238-666-2) (Wayne, Pennsylvania, USA, Clinical and Laboratory Standards Institute, 2008)."},{"key":"21866_CR93","doi-asserted-by":"publisher","first-page":"165","DOI":"10.3390\/pathogens10020165","volume":"10","author":"B Kowalska-Krochmal","year":"2021","unstructured":"Kowalska-Krochmal, B. & Dudek-Wicher, R. The minimum inhibitory concentration of antibiotics: methods, interpretation, clinical relevance. Pathogens 10, 165 (2021).","journal-title":"Pathogens"},{"key":"21866_CR94","doi-asserted-by":"publisher","DOI":"10.3791\/55064","author":"KL Hockett","year":"2017","unstructured":"Hockett, K. L. & Baltrus, D. A. Use of the Soft-agar overlay technique to screen for bacterially produced inhibitory compounds. J. Vis. Exp. https:\/\/doi.org\/10.3791\/55064 (2017).","journal-title":"J. Vis. Exp."},{"key":"21866_CR95","doi-asserted-by":"publisher","first-page":"106596","DOI":"10.1016\/j.mimet.2022.106596","volume":"202","author":"ML Hossain","year":"2022","unstructured":"Hossain, M. L. et al. Optimisation of an agar overlay assay for the assessment of the antimicrobial activity of topically applied semi-solid antiseptic products including honey-based formulations. J. Microbiol. Methods. 202, 106596 (2022).","journal-title":"J. Microbiol. Methods"},{"key":"21866_CR96","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1128\/AAC.00471-08","volume":"53","author":"GV Tetz","year":"2009","unstructured":"Tetz, G. V., Artemenko, N. K. & Tetz, V. V. Effect of DNase and antibiotics on biofilm characteristics. Antimicrob. Agents Chemother. 53, 1204\u20131209 (2009).","journal-title":"Antimicrob. Agents Chemother."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-21866-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-21866-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-21866-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T14:04:22Z","timestamp":1761833062000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-21866-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,30]]},"references-count":96,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["21866"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-21866-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,30]]},"assertion":[{"value":"12 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"37988"}}